COVID-19 Project Team: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 16: | Line 16: | ||
*'''[[User:Mandana Chitsazan|Mandana Chitsazan, M.D.]]''' | *'''[[User:Mandana Chitsazan|Mandana Chitsazan, M.D.]]''' | ||
*'''[[User:Mitra Chitsazan|Mitra Chitsazan]]''' | *'''[[User:Mitra Chitsazan|Mitra Chitsazan]]''' | ||
*Mandana Safakhah | *[[User:Mandana Safakhah|Mandana Safakhah]] | ||
*Mounika Vadiyala | *[[User:Mounika|Mounika Vadiyala]] | ||
* | *Sara Haddadi | ||
*Sara Zand | *Sara Zand | ||
*Syed Rizvi | *Syed Rizvi | ||
| Line 58: | Line 58: | ||
*[[User:Gurman4sandhu|Gurmandeep Singh Sandhu, M.B.B.S.]] | *[[User:Gurman4sandhu|Gurmandeep Singh Sandhu, M.B.B.S.]] | ||
*[[User:NNikravangolsefid|Nasrin Nikravangolsefid, M.D, MPH]] | *[[User:NNikravangolsefid|Nasrin Nikravangolsefid, M.D, MPH]] | ||
*Mydah Sajid | *[[User:MydahSajid|Mydah Sajid, M.D.]] | ||
'''Neurologic Disorders and COVID-19 Team Members''' | '''Neurologic Disorders and COVID-19 Team Members''' | ||
| Line 64: | Line 64: | ||
*'''[[User:Syed Musadiq Ali|Syed Musadiq Ali, M.D.]]''' | *'''[[User:Syed Musadiq Ali|Syed Musadiq Ali, M.D.]]''' | ||
*'''[[User:Niloofarsadaat Eshaghhosseiny|Niloofarsadaat Eshagh Hosseiny, M.D.]]''' | *'''[[User:Niloofarsadaat Eshaghhosseiny|Niloofarsadaat Eshagh Hosseiny, M.D.]]''' | ||
*Muhammad Adnan Haider | *[[User:Muhammad Haider|Muhammad Adnan Haider]] | ||
*[[User:Agnesrinky|Rinky Agnes Botleroo, M.B.B.S.]] | *[[User:Agnesrinky|Rinky Agnes Botleroo, M.B.B.S.]] | ||
'''Ongoing Clinical Trials of COVID-19 Team Members''' | '''Ongoing Clinical Trials of COVID-19 Team Members''' | ||
Revision as of 16:29, 17 June 2020
| COVID-19 Project |
|---|
| Introduction |
| Team |
| Meetings' Summary |
| Topics |
| Ongoing Clinical Trials |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Meet The Team
Associate Editor(s)-in-Chief:
- The name of the leaders are written in bold:
Cardiovascular Disorders of COVID-19 Team Members
- Alieh Bahjat
- Mandana Chitsazan, M.D.
- Mitra Chitsazan
- Mandana Safakhah
- Mounika Vadiyala
- Sara Haddadi
- Sara Zand
- Syed Rizvi
- Tayyaba Ali, M.D.
Dermatologic Disorders of COVID-19 Team Members
Frequently Asked Inpatient Questions Team Members
- Gurmandeep Singh Sandhu, M.B.B.S.
- Aisha Adigun, M.D.
- Harmeet Kharoud, M.D,. MPH
- Rinky Agnes Botleroo, M.B.B.S.
- Nuha AL-Howthi, MD
- Ifrah Fatima, M.B.B.S
- Ogechukwu Hannah Nnabude, MD
Frequently Asked Outpatient Questions Team Members
- Roukoz Abou Karam, M.D.
- Aisha Adigun, M.D.
- Bosky Soni, M.D., MPH
- Neepa Shah, M.D
- Indhumathi Venkatasubramani balaraman, M.D.
Gastrointestinal disorders and of COVID-19
- Farima Kahe
- Tayyaba Ali, M.D.
Hematologic disorders of COVID-19 Team Members
- Ramyar Ghandriz, M.D.
- Ifrah Fatima, M.B.B.S
- Shakiba Hassanzadeh
- Fausat Adogba
Nephrologic Disorders of COVID-19 Team Members
- Sogand Goudarzi, M.D.
- Gurmandeep Singh Sandhu, M.B.B.S.
- Nasrin Nikravangolsefid, M.D, MPH
- Mydah Sajid, M.D.
Neurologic Disorders and COVID-19 Team Members
- Fahimeh Alsadat Shojaei, M.D.
- Syed Musadiq Ali, M.D.
- Niloofarsadaat Eshagh Hosseiny, M.D.
- Muhammad Adnan Haider
- Rinky Agnes Botleroo, M.B.B.S.
Ongoing Clinical Trials of COVID-19 Team Members
Pediatrics and COVID-19
Pulmonary Disorders and COVID-19 Team Members
- Sara Mohsin, M.B.B.S.
- Ayesha Farheen Javid
- Usman Ali akbar
- Rina Ghorpade
- Rana Aljebzi (not trained yet)